Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets OTCPK - Delayed Quote USD

Aspen Pharmacare Holdings Limited (APNHF)

Compare
12.24
0.00
(0.00%)
At close: April 3 at 4:00:00 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Stephen Bradley Saad BCom, CA(SA) Group CEO & Executive Director 1.18M -- 1964
Mr. Sean M. Capazorio Group CFO & Executive Director 587.43k -- 1967
Ms. Lorraine Hill Group Chief Operations Officer 620.47k -- 1964
Mr. Michael Guy Attridge B.Com., CA(SA) Group Chief Advisor 410.4k -- 1961
Mr. Reginald Haman Grad. Dip., MBA, ND, NHD, PGDBA Group Chief Corporate Officer & Executive Director 491.14k -- 1975
Ms. Zizipho Mmango Group Chief Strategic Development Officer 442.86k -- 1985
Ms. Sibongakonke Nkosi Investor Relations Manager -- -- --
Ms. Raeesa Khan Group Company Secretary & Chief of Staff -- -- --
Mr. Trevor Julian Ziman Regional Chief Executive Officer of Asia Pacific -- -- 1972
Mr. Samer Kassem Chief Executive Officer of Aspen Global Incorporated -- -- 1975

Aspen Pharmacare Holdings Limited

Aspen Place
9 Rydall Vale Park Douglas Saunders Drive La Lucia Ridge
Durban
South Africa
27 31 580 8600 https://www.aspenpharma.com
Sector: 
Healthcare
Full Time Employees: 
8,867

Description

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general, local, and regional anesthetic; low molecular weight heparin; regional and spinal anesthetic; and opioid analegesic under the Diprivan, Emla, Fraxiparine, Marcaine, Ultiva, and Xylocaine brand names. It also offers such as sleeping aid, thyroid hormone, immunosuppressant, iron supplement, analgesic anti-inflammatory, and hormone replacement therapy under the Circadin, Eltroxin, Foxair, Imuran, Maltofer, Mybulen, and Ovestin brand names. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.

Corporate Governance

Aspen Pharmacare Holdings Limited’s ISS Governance QualityScore as of April 1, 2025 is 6. The pillar scores are Audit: 7; Board: 8; Shareholder Rights: 3; Compensation: 3.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

March 3, 2025 at 11:00 AM UTC

Aspen Pharmacare Holdings Limited Earnings Date

Recent Events

September 18, 2024 at 12:00 AM UTC

Ex-Dividend Date

October 9, 2017 at 12:00 AM UTC

Dividend Date

Related Tickers